Literature DB >> 6161973

Sensitivity of herpes simplex virus types 1 and 2 to three preparations of human interferon.

J C Overall, T J Yeh, E R Kern.   

Abstract

Ten isolates of herpes simplex virus (HSV) type 1 and nine isolates of HSV type 2 were tested against virus-induced (alpha), fibroblast (beta), and mitogen-induced (gamma) preparations of human interferon (HuIFN). HSV type 2 was slightly more sensitive and HSV type 1 somewhat less sensitive to all three preparations of HuIFN than Sindbis and vesicular stomatitis virus-both considered to be quite sensitive to HuIFN. HSV type 2 was significantly more sensitive than HSV type 1 to each of the HuIFN preparations (P less than 0.01; Mann-Whitney ranksum test). Clinical isolates did not appear to differ from laboratory strains. These results indicate that both HSV types 1 and 1 are sensitive to the three different preparations of HuIFN. HuIFN may have a role in natural recovery from and may have potential as an antriviral chemotherapeutic agent in HSV infections in humans.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6161973     DOI: 10.1093/infdis/142.6.943

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism.

Authors:  K D Ryman; W B Klimstra; K B Nguyen; C A Biron; R E Johnston
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Current recommendations for the treatment of genital herpes.

Authors:  D T Leung; S L Sacks
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

3.  Therapy of genital herpes with topically applied interferon.

Authors:  L J Eron; C Toy; B Salsitz; R R Scheer; D L Wood; P I Nadler
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

4.  Biosynthetic human interferon treatment of herpetic keratitis.

Authors:  G Smolin
Journal:  Trans Am Ophthalmol Soc       Date:  1983

5.  Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice.

Authors:  R D Dix; R R McKendall; J R Baringer
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

6.  Sensitivity in vitro of herpes simplex virus isolates to human fibroblast interferon.

Authors:  S Leventon-Kriss; M Movshovitz; Z Smetana; M Shewach-Millet; T Doerner; T Gotlieb-Stematsky
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

7.  Pathogenesis of herpes simplex labialis: correlation of vesicle fluid interferon with lesion age and virus titer.

Authors:  S L Spruance; J A Green; G Chiu; T J Yeh; G Wenerstrom; J C Overall
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  Interferon susceptibility of herpes simplex virus strains isolated from patients enrolled in clinical trials.

Authors:  J A Armstrong; M B Skicki-Mullen; M K Breinig; M Ho
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

9.  Synergistic activity of combinations of recombinant human alpha interferon and acyclovir, administered concomitantly and in sequence, against a lethal herpes simplex virus type 1 infection in mice.

Authors:  E V Connell; R L Cerruti; P W Trown
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

10.  Antiviral effects of bovine interferons on bovine respiratory tract viruses.

Authors:  R W Fulton; M M Downing; J M Cummins
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.